Not available
Quote | Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Last: | $397.48 |
---|---|
Change Percent: | 1.05% |
Open: | $393.52 |
Close: | $397.48 |
High: | $399.68 |
Low: | $393.49 |
Volume: | 681,879 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
- KALYDECO ® is the first and only medicine approved in the EU in this age group to treat the underlying cause of cystic fibrosis for specific mutations in the CFTR gene - Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has gra...
2024-04-25 09:45:00 ET While some stocks have responded to the 2024 bull market better than others, an abundance of stocks have followed this rising tide. There's no predicting how long this next bull market will last, although historically speaking, these periods tend to significantly outl...
Message Board Posts | Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $VRTX News Article - This Is My Highest-Conviction Stock to Own in 2023 and Beyond | whytestocks | investorshangout | 03/23/2023 7:05:46 PM |
whytestocks: $VRTX News Article - 2 No-Brainer Biotech Stocks to Buy Right Now | whytestocks | investorshangout | 12/22/2022 8:20:45 PM |
whytestocks: $VRTX News Article - Vertex to Participate in Upcoming Investor Conferences | whytestocks | investorshangout | 11/09/2022 6:55:51 PM |
whytestocks: $VRTX News Article - Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory | whytestocks | investorshangout | 09/27/2022 4:06:04 PM |
FDA approval for Cystic Fibrosis drug for children. Why | Glider549 | investorshub | 09/06/2022 1:26:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Vertex Pharmaceuticals Incorporated Company Name:
VRTX Stock Symbol:
NASDAQ Market:
- KALYDECO ® is the first and only medicine approved in the EU in this age group to treat the underlying cause of cystic fibrosis for specific mutations in the CFTR gene - Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has gra...
2024-04-25 09:45:00 ET While some stocks have responded to the 2024 bull market better than others, an abundance of stocks have followed this rising tide. There's no predicting how long this next bull market will last, although historically speaking, these periods tend to significantly outl...
2024-04-23 06:05:00 ET Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known for its expertise in treating cystic fibrosis (CF). The biotech is the market leader, bringing in billions of dollars in revenue and profit annually from its CF drugs. And that's likely to continue than...